Combination With Intranasal Dexmedetomidine and Oral Midazolam for Premedication in Pediatric Patients
Condition(s):AnxietyLast Updated:November 5, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):AnxietyLast Updated:November 5, 2019Unknown status
Condition(s):Pediatric Cancer; Analgesia; Procedural PainLast Updated:April 1, 2021Unknown status
Condition(s):Emergence DeliriumLast Updated:July 13, 2018Completed
Condition(s):Preoperative SedationLast Updated:July 7, 2017Completed
Condition(s):Pediatric DeliriumLast Updated:May 26, 2023Recruiting
Condition(s):Deep Sedation; DexmedetomidineLast Updated:February 10, 2023Completed
Condition(s):HealthyLast Updated:February 17, 2017Completed
Condition(s):Safety and Efficacy of Intranasal DexmedetomidineLast Updated:December 7, 2016Unknown status
Condition(s):AnxietyLast Updated:June 29, 2023Recruiting
Condition(s):Procedural Anxiety; EmergenciesLast Updated:September 30, 2022Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.